Tomasz Kucharczyk

Lublin, LU, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Identification of Thermobifida fusca as a main causative agent of mushroom compost worker's lung - case series.

Identification of Thermobifida fusca as a main causative agent of mushroom compost worker's lung - case series.

Journal: Annals of agricultural and environmental medicine : AAEM

Published: June 30, 2026

When genetics meets immunology: the assessment of genetic and immunological backgrounds in advanced NSCLC patients treated with immunotherapy - preliminary study.

When genetics meets immunology: the assessment of genetic and immunological backgrounds in advanced NSCLC patients treated with immunotherapy - preliminary study.

Journal: Journal of applied genetics

Published: January 28, 2025

NRG1 Gene Fusions-What Promise Remains Behind These Rare Genetic Alterations? A Comprehensive Review of Biology, Diagnostic Approaches, and Clinical Implications.

NRG1 Gene Fusions-What Promise Remains Behind These Rare Genetic Alterations? A Comprehensive Review of Biology, Diagnostic Approaches, and Clinical Implications.

Journal: Cancers

Published: July 11, 2024

Harnessing the power of AI in precision medicine: NGS-based therapeutic insights for colorectal cancer cohort.

Harnessing the power of AI in precision medicine: NGS-based therapeutic insights for colorectal cancer cohort.

Journal: Frontiers in oncology

Published: March 26, 2024

Immunological insights: assessing immune parameters in medical professionals exposed to SARS-CoV-2.

Immunological insights: assessing immune parameters in medical professionals exposed to SARS-CoV-2.

Journal: BMC infectious diseases

Published: October 24, 2023

Obesity and lung cancer - is programmed death ligand-1 (PD-1L) expression a connection?

Obesity and lung cancer - is programmed death ligand-1 (PD-1L) expression a connection?

Journal: Archives of medical science : AMS

Published: September 13, 2023

Creating an Innovative Artificial Intelligence-Based Technology (TCRact) for Designing and Optimizing T Cell Receptors for Use in Cancer Immunotherapies: Protocol for an Observational Trial.

Creating an Innovative Artificial Intelligence-Based Technology (TCRact) for Designing and Optimizing T Cell Receptors for Use in Cancer Immunotherapies: Protocol for an Observational Trial.

Journal: JMIR research protocols

Published: February 08, 2023

Attempting to Identify Bacterial Allies in Immunotherapy of NSCLC Patients.

Attempting to Identify Bacterial Allies in Immunotherapy of NSCLC Patients.

Journal: Cancers

Published: November 16, 2022

RET Proto-Oncogene-Not Such an Obvious Starting Point in Cancer Therapy.

RET Proto-Oncogene-Not Such an Obvious Starting Point in Cancer Therapy.

Journal: Cancers

Published: September 06, 2022

Immunotherapy in Non-Small-Cell Lung Cancer Patients with Driver Alterations: A New Strategy?

Immunotherapy in Non-Small-Cell Lung Cancer Patients with Driver Alterations: A New Strategy?

Journal: Cells

Published: August 21, 2022

Presence of Akkermansiaceae in gut microbiome and immunotherapy effectiveness in patients with advanced non-small cell lung cancer.

Presence of Akkermansiaceae in gut microbiome and immunotherapy effectiveness in patients with advanced non-small cell lung cancer.

Journal: AMB Express

Published: March 28, 2022

Deep learning-based tumor microenvironment segmentation is predictive of tumor mutations and patient survival in non-small-cell lung cancer.

Deep learning-based tumor microenvironment segmentation is predictive of tumor mutations and patient survival in non-small-cell lung cancer.

Journal: BMC cancer

Published: December 28, 2021

Showing 1-12 of 31

Last Updated: 09/26/2026